Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure - Effect of physician specialty and patient characteristics

被引:50
作者
Chin, MH
Wang, JC
Zhang, JX
Lang, RM
机构
[1] Section of General Internal Medicine, Department of Medicine, University of Chicago Medical Center, Chicago, IL
[2] Section of Cardiology, Department of Medicine, University of Chicago Medical Center, Chicago, IL
[3] Pritzker School of Medicine, University of Chicago, Medical Center, Chicago, IL
[4] Department of Medicine, Brigham and Women's Hospital, Boston, MA
[5] University of Chicago Medical Center, Section of General Internal Medicine, MC 6098, Chicago, IL 60637
关键词
angiotensin-converting enzyme (ACE) inhibitor; congestive heart failure; physician behavior; specialty; quality of care;
D O I
10.1046/j.1525-1497.1997.07110.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
To determine if physician specialty is associated with underutilization and underdosing of angiotensin-converting enzyme inhibitors among patients with heart failure, we reviewed the charts of 214 outpatients with decreased systolic function at an urban academic medical center. Regardless of whether patients were cared for by cardiologists, generalist physicians, or a combination of the two specialties, approximately 75% of the patients were taking an angiotensin-converting enzyme inhibitor, However, only approximately 60% of these patients were taking dosages proved to be efficacious in trials. Emphasis on adequate dosing is needed among all specialty groups.
引用
收藏
页码:563 / 566
页数:4
相关论文
共 20 条
  • [11] O'Connell J B, 1996, J Miss State Med Assoc, V37, P648
  • [12] Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
    Packer, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (05) : 1323 - 1327
  • [13] EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
    PFEFFER, MA
    BRAUNWALD, E
    MOYE, LA
    BASTA, L
    BROWN, EJ
    CUDDY, TE
    DAVIS, BR
    GELTMAN, EM
    GOLDMAN, S
    FLAKER, GC
    KLEIN, M
    LAMAS, GA
    PACKER, M
    ROULEAU, J
    ROULEAU, JL
    RUTHERFORD, J
    WERTHEIMER, JH
    HAWKINS, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) : 669 - 677
  • [14] Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
    Philbin, EF
    Andreou, C
    Rocco, TA
    Lynch, LJ
    Baker, SL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (10) : 832 - 838
  • [15] PERSPECTIVE OF THE PHARMACEUTICAL-INDUSTRY ON THE DEVELOPMENT OF NEW DRUGS FOR HEART-FAILURE
    RAJFER, SI
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : A198 - A200
  • [16] *SOLVD INV, 1981, NEW ENGL J MED, V325, P293
  • [17] *US HLTH CAR FIN A, 1991, INT CLASS DIS
  • [18] Current controversies with ACE inhibitor treatment in heart failure
    Visser, FC
    Visser, CA
    [J]. CARDIOLOGY, 1996, 87 : 23 - 28
  • [19] WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376
  • [20] PATTERNS OF MEDICATION USE IN PATIENTS WITH HEART-FAILURE - A REPORT FROM THE REGISTRY OF STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD)
    YOUNG, JB
    WEINER, DH
    YUSUF, S
    PRATT, CM
    KOSTIS, JB
    WEISS, MB
    SCHROEDER, E
    GUILLOTE, M
    [J]. SOUTHERN MEDICAL JOURNAL, 1995, 88 (05) : 514 - 523